Sarepta Therapeutics (SRPT) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 189.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189.48% |
| Dec 31, 2025 | -449.46% |
| Sep 30, 2025 | -670.63% |
| Jun 30, 2025 | 1,031.60% |
| Mar 31, 2025 | -1,025.30% |
| Dec 31, 2024 | -71.46% |
| Sep 30, 2024 | 202.51% |
| Jun 30, 2024 | 193.09% |
| Mar 31, 2024 | 108.08% |
| Dec 31, 2023 | -17.27% |
| Sep 30, 2023 | 87.06% |
| Jun 30, 2023 | 93.61% |
| Mar 31, 2023 | -392.30% |
| Dec 31, 2022 | 554.20% |
| Sep 30, 2022 | -435.24% |
| Jun 30, 2022 | -178.98% |
| Mar 31, 2022 | 37.78% |
| Dec 31, 2021 | 60.60% |
| Sep 30, 2021 | 75.61% |
| Jun 30, 2021 | 45.78% |
| Mar 31, 2021 | -863.30% |
| Dec 31, 2020 | 19.79% |
| Sep 30, 2020 | -55.75% |
| Jun 30, 2020 | 45.41% |
| Mar 31, 2020 | 77.30% |
| Dec 31, 2019 | -65.87% |
| Sep 30, 2019 | -63.62% |
| Jun 30, 2019 | -154.25% |
| Mar 31, 2019 | -117.35% |
| Dec 31, 2018 | -448.27% |
| Sep 30, 2018 | -68.55% |
| Jun 30, 2018 | -72.03% |
| Mar 31, 2018 | -140.92% |
| Dec 31, 2017 | 70.79% |
| Sep 30, 2017 | 19.42% |
| Jun 30, 2017 | -1.37% |
| Mar 31, 2017 | 244.04% |
| Dec 31, 2016 | -37.24% |
| Sep 30, 2016 | -9.62% |
| Jun 30, 2016 | -47.96% |
| Mar 31, 2016 | 3.38% |
| Dec 31, 2015 | -44.12% |
| Sep 30, 2015 | -53.71% |
| Jun 30, 2015 | -39.10% |
| Mar 31, 2015 | -146.26% |
| Dec 31, 2014 | -36.14% |
| Sep 30, 2014 | -35.40% |
| Jun 30, 2014 | -76.96% |
| Mar 31, 2014 | -65.51% |
| Dec 31, 2013 | -219.45% |
| Sep 30, 2013 | -263.70% |
| Jun 30, 2013 | -213.87% |
| Mar 31, 2013 | -123.93% |
| Dec 31, 2012 | -16.15% |
| Sep 30, 2012 | 38.24% |
| Jun 30, 2012 | 45.36% |
| Mar 31, 2012 | -24.57% |
| Dec 31, 2011 | -436.22% |
| Sep 30, 2011 | -198.03% |
| Jun 30, 2011 | -30.96% |